Yi Yang1, Zi-Jiao Chen1, Su Yan1. 1. Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract
BACKGROUND: Although advances in the treatment of stage IV gastric cancer (GC) patients, some patients were observed to die within 3 months of initial diagnosis. The present study aimed to explore the early mortality and risk factors for stage IV GC and further develop nomograms. METHODS: A total of 2,174 eligible stage IV GC patients were selected from the Surveillance, Epidemiology, and End Results database. Logistic regression analyses were used to determine the risk factors and develop the nomograms to predict all-cause early death and cancer-specific early death. The predictive performance of the nomograms was assessed by receiver operating characteristic curves (ROC), calibration plots and decision curve analyses (DCA) in both training and validation cohorts. RESULTS: Of 2,174 patients enrolled, 708 died within 3 months of initial diagnosis (n=668 for cancer-specific early death). Early mortality remained stable from 2010-2015. Non-Asian or Pacific Islander (API) race, poorer differentiation, middle sites of the stomach, no surgery, no radiotherapy, no chemotherapy, lung metastases and liver metastases were associated with high risk of both all-causes early death and cancer-specific early death. The nomograms constructed based on these factors showed favorable sensitivity, with the area under the ROC range of 0.816-0.847. The calibration curves and DCAs also exhibited adequate fit and ideal net benefit in prediction and clinical application. CONCLUSIONS: Approximately one-third of stage IV GC patients experienced early death. These associated risk factors and predictive nomograms may help clinicians identify the patients at high risk of early death and be the reference for treatment choices. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Although advances in the treatment of stage IV gastric cancer (GC) patients, some patients were observed to die within 3 months of initial diagnosis. The present study aimed to explore the early mortality and risk factors for stage IV GC and further develop nomograms. METHODS: A total of 2,174 eligible stage IV GC patients were selected from the Surveillance, Epidemiology, and End Results database. Logistic regression analyses were used to determine the risk factors and develop the nomograms to predict all-cause early death and cancer-specific early death. The predictive performance of the nomograms was assessed by receiver operating characteristic curves (ROC), calibration plots and decision curve analyses (DCA) in both training and validation cohorts. RESULTS: Of 2,174 patients enrolled, 708 died within 3 months of initial diagnosis (n=668 for cancer-specific early death). Early mortality remained stable from 2010-2015. Non-Asian or Pacific Islander (API) race, poorer differentiation, middle sites of the stomach, no surgery, no radiotherapy, no chemotherapy, lung metastases and liver metastases were associated with high risk of both all-causes early death and cancer-specific early death. The nomograms constructed based on these factors showed favorable sensitivity, with the area under the ROC range of 0.816-0.847. The calibration curves and DCAs also exhibited adequate fit and ideal net benefit in prediction and clinical application. CONCLUSIONS: Approximately one-third of stage IV GC patients experienced early death. These associated risk factors and predictive nomograms may help clinicians identify the patients at high risk of early death and be the reference for treatment choices. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Gastric cancer (GC); Surveillance, Epidemiology, and End Results (SEER); early death; nomogram; stage IV
Authors: Melissa A Jim; Paulo S Pinheiro; Helena Carreira; David K Espey; Charles L Wiggins; Hannah K Weir Journal: Cancer Date: 2017-12-15 Impact factor: 6.860
Authors: Sun Young Kim; Min Joo Yoon; Young Iee Park; Mi Jung Kim; Byung-Ho Nam; Sook Ryun Park Journal: Gastric Cancer Date: 2017-08-21 Impact factor: 7.370
Authors: Xin Wang; Min Mao; Guijun Xu; Feng Lin; Peng Sun; Vladimir P Baklaushev; Vladimir P Chekhonin; Karl Peltzer; Jin Zhang; Chao Zhang Journal: Int J Colorectal Dis Date: 2019-05-15 Impact factor: 2.571
Authors: Sachin Wani; Jennifer Drahos; Michael B Cook; Amit Rastogi; Ajay Bansal; Roy Yen; Prateek Sharma; Ananya Das Journal: Gastrointest Endosc Date: 2013-09-20 Impact factor: 9.427
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702